Amphastar Pharma (AMPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 145,712 | 140,022 | 135,023 | 120,129 | 123,467 |
| Cost of Goods | 72,974 | 66,182 | 63,855 | 61,619 | 60,111 |
| Gross Profit | 72,738 | 73,840 | 71,168 | 58,510 | 63,356 |
| Operating Expenses | 36,816 | 40,589 | 34,191 | 35,901 | 38,644 |
| Operating Income | 36,896 | 33,433 | 37,832 | 23,228 | 24,823 |
| Interest Expense | 3,602 | 398 | 528 | 566 | 397 |
| Other Income | -787 | -251 | 3,899 | -229 | -1,529 |
| Pre-tax Income | 32,507 | 32,784 | 41,203 | 22,433 | 22,897 |
| Income Tax | 6,383 | 6,752 | 7,290 | 6,559 | 5,551 |
| Net Income Continuous | 26,124 | 26,032 | 33,913 | 15,874 | 17,346 |
| Net Income | $26,124 | $26,032 | $33,913 | $15,874 | $17,346 |
| EPS Basic Total Ops | 0.54 | 0.54 | 0.71 | 0.32 | 0.35 |
| EPS Basic Continuous Ops | 0.54 | 0.54 | 0.70 | 0.32 | 0.36 |
| EPS Diluted Total Ops | 0.49 | 0.50 | 0.64 | 0.30 | 0.33 |
| EPS Diluted Continuous Ops | 0.49 | 0.50 | 0.65 | 0.30 | 0.33 |
| EBITDA(a) | $46,185 | $39,985 | $44,286 | $29,902 | $30,963 |